Anti-cancer Vaccine Approved For Research In Shanghai
November 24, 2004 |
Print
|
Email
|
Comments | Category: Science
The first Chinese-developed cancer vaccine that was patented abroad has now received permission from the State Food and Drug Administration for clinical tests in Shanghai. The vaccine specifically aims at eradicating liver cancer cells from infected patients.
The No. 2 Medical University of the Chinese People's Liberation Army has worked on the vaccine in collaboration with a Shanghai laboratory that deals with animal cell engineering.
Data from the Ministry of Health showed that the death rate from malignant cancer tumors grew by 29% percent between the1970s and the 1990s in China.
Related Links:
Leave A Comment:
Inside ChinaTechNews.com
-
Security
- Qihoo 360's Safebox Software Will Integrate With Uuu9.com
- Apple Suspends iPhone 4S Sales In Retail Stores In China
- New Chinese Internet Rules Focus On Data Security, Web Advertising
- Chinese Internet Users Can Report Online Fraudsters Via New Baidu Service
- Huawei To Acquire 49% Stake In Security JV With Symantec
-
Software
-
Telecom & Wireless
Visit these other China sites: ChinaRetailNews.com | GreenChinaTech.com
| ChinaWirelessNews.com
| TechSecurityChina.com
| China Sourcing News
| China CSR





